What 9 Analyst Ratings Have To Say About Roivant Sciences
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 9 analysts have published their opinion on Roivant Sciences (NASDAQ:ROIV) stock. The average price target is $16.94, a 0.35% decrease from the previous average price target of $17.00. The majority of the ratings are bullish.
August 31, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Roivant Sciences (NASDAQ:ROIV) has received mostly bullish ratings from 9 analysts over the past 3 months. The average price target is $16.94, a 0.35% decrease from the previous average price target of $17.00.
The majority of the analysts have given bullish ratings to Roivant Sciences, indicating a positive outlook for the stock. However, the slight decrease in the average price target could suggest some caution. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100